Tag: EMA
Browse our exclusive articles!
Corona Influenza: First Combined Test in the US
Influenza currently hardly plays a role in Europe when it comes to flu or flu-like infections. But the next seasonal flu wave will...
Vaccination against RSV infections in the starting blocks
Vaccines against infection or serious illness caused by respiratory syncytial virus (RSV) for the elderly could be available soon. Successful studies recently appeared...
New variants: Corona medicines ‘not very effective’
The EU medicines agency EMA has warned of the declining effectiveness of several antibody-based corona drugs against the latest sub-variants of the virus. ...
Especially many children with respiratory diseases
The respiratory syncytial virus (RSV) is particularly difficult for small children in the cold season. The most common reason babies and infants are...
BA.4/BA.5 vaccine also for children from the age of five
The European Medicines Agency (EMA) has recommended the approval of Biontech/Pfizer's Corona vaccine, which is adapted to Omicron variants BA.4/BA.5, for children over the...
